172 related articles for article (PubMed ID: 16177126)
1. Induction of apoptosis by the hydrocarbon oil pristane: implications for pristane-induced lupus.
Calvani N; Caricchio R; Tucci M; Sobel ES; Silvestris F; Tartaglia P; Richards HB
J Immunol; 2005 Oct; 175(7):4777-82. PubMed ID: 16177126
[TBL] [Abstract][Full Text] [Related]
2. X-linked immunodeficient mice spontaneously produce lupus-related anti-RNA helicase A autoantibodies, but are resistant to pristane-induced lupus.
Satoh M; Mizutani A; Behney KM; Kuroda Y; Akaogi J; Yoshida H; Nacionales DC; Hirakata M; Ono N; Reeves WH
Int Immunol; 2003 Sep; 15(9):1117-24. PubMed ID: 12917264
[TBL] [Abstract][Full Text] [Related]
3. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane.
Satoh M; Reeves WH
J Exp Med; 1994 Dec; 180(6):2341-6. PubMed ID: 7964507
[TBL] [Abstract][Full Text] [Related]
4. The natural killer T cell ligand alpha-galactosylceramide prevents or promotes pristane-induced lupus in mice.
Singh AK; Yang JQ; Parekh VV; Wei J; Wang CR; Joyce S; Singh RR; Van Kaer L
Eur J Immunol; 2005 Apr; 35(4):1143-54. PubMed ID: 15761849
[TBL] [Abstract][Full Text] [Related]
5. Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice.
Richards HB; Satoh M; Jennette JC; Okano T; Kanwar YS; Reeves WH
Clin Exp Immunol; 1999 Mar; 115(3):547-53. PubMed ID: 10193432
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
[TBL] [Abstract][Full Text] [Related]
7. Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane.
Satoh M; Richards HB; Shaheen VM; Yoshida H; Shaw M; Naim JO; Wooley PH; Reeves WH
Clin Exp Immunol; 2000 Aug; 121(2):399-405. PubMed ID: 10931159
[TBL] [Abstract][Full Text] [Related]
8. Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model.
Zeggar S; Watanabe KS; Teshigawara S; Hiramatsu S; Katsuyama T; Katsuyama E; Watanabe H; Matsumoto Y; Kawabata T; Sada KE; Niki T; Hirashima M; Wada J
Arthritis Rheumatol; 2018 Jul; 70(7):1089-1101. PubMed ID: 29481735
[TBL] [Abstract][Full Text] [Related]
9. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
Summers SA; Hoi A; Steinmetz OM; O'Sullivan KM; Ooi JD; Odobasic D; Akira S; Kitching AR; Holdsworth SR
J Autoimmun; 2010 Dec; 35(4):291-8. PubMed ID: 20810248
[TBL] [Abstract][Full Text] [Related]
10. Role of reactive intermediates in the immunopathogenesis of the pristane-induced Balb/c model of lupus.
Minhas U; Das P; Bhatnagar A
Lupus; 2011 Nov; 20(13):1421-5. PubMed ID: 22095888
[TBL] [Abstract][Full Text] [Related]
11. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Autoimmunity and Renal Disease in Pristane-Induced Lupus by Myeloperoxidase.
Odobasic D; Muljadi RC; O'Sullivan KM; Kettle AJ; Dickerhof N; Summers SA; Kitching AR; Holdsworth SR
Arthritis Rheumatol; 2015 Jul; 67(7):1868-80. PubMed ID: 25777776
[TBL] [Abstract][Full Text] [Related]
13. Induction of lupus autoantibodies by adjuvants.
Satoh M; Kuroda Y; Yoshida H; Behney KM; Mizutani A; Akaogi J; Nacionales DC; Lorenson TD; Rosenbauer RJ; Reeves WH
J Autoimmun; 2003 Aug; 21(1):1-9. PubMed ID: 12892730
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice.
Chae BS; Shin TY; Kim DK; Eun JS; Leem JY; Yang JH
Arch Pharm Res; 2008 Apr; 31(4):503-10. PubMed ID: 18449509
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors.
Clynes R; Calvani N; Croker BP; Richards HB
Clin Exp Immunol; 2005 Aug; 141(2):230-7. PubMed ID: 15996187
[TBL] [Abstract][Full Text] [Related]
16. Target silencing of disease-associated B-lymphocytes by chimeric molecules in SCID model of pristane-induced autoimmunity.
Dimitrova I; Gesheva V; Nikolova K; Mihaylova N; Todorov T; Nikolova M; Tchorbanov A
Lupus; 2010 Oct; 19(11):1261-71. PubMed ID: 20530521
[TBL] [Abstract][Full Text] [Related]
17. C1q Modulates the Response to TLR7 Stimulation by Pristane-Primed Macrophages: Implications for Pristane-Induced Lupus.
Carlucci F; Ishaque A; Ling GS; Szajna M; Sandison A; Donatien P; Cook HT; Botto M
J Immunol; 2016 Feb; 196(4):1488-94. PubMed ID: 26773156
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3 orchestrates the histology of mesentery and protects liver during lupus-like syndrome induced by pristane.
Lemos FS; Pereira JX; Carvalho VF; Bernardes ES; Chammas R; Pereira TM; Carvalho RS; Luisetto R; El-Cheikh MC; Calil-Elias S; Oliveira FL
Sci Rep; 2019 Oct; 9(1):14620. PubMed ID: 31601823
[TBL] [Abstract][Full Text] [Related]
19. Milk fat globule-EGF factor 8 suppresses the aberrant immune response of systemic lupus erythematosus-derived neutrophils and associated tissue damage.
Huang W; Wu J; Yang H; Xiong Y; Jiang R; Cui T; Ye D
Cell Death Differ; 2017 Feb; 24(2):263-275. PubMed ID: 27768123
[TBL] [Abstract][Full Text] [Related]
20. Cell death and cytokine production induced by autoimmunogenic hydrocarbon oils.
Herman S; Kny A; Schorn C; Pfatschbacher J; Niederreiter B; Herrmann M; Holmdahl R; Steiner G; Hoffmann MH
Autoimmunity; 2012 Dec; 45(8):602-11. PubMed ID: 22917079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
